RenovoRx (RNXT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
RenovoRx, Inc. is on the brink of being delisted from The Nasdaq Capital Market for failing to meet the minimum stockholders’ equity requirement. Despite receiving an extension until February 19, 2024, to resolve the issue, the company was still non-compliant as of the notice date. RenovoRx intends to request a hearing to postpone delisting and will present plans to regain compliance, buoyed by a recent private placement that raised $6.1 million. While the company is optimistic about meeting the requirements, there is no certainty that it will achieve compliance in time to avoid delisting.
For further insights into RNXT stock, check out TipRanks’ Stock Analysis page.
